Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy

被引:8
|
作者
Lin, Baiqiang [3 ]
Zhao, Fuya [3 ,6 ]
Liu, Yang [1 ,2 ,3 ]
Sun, Jiayu [3 ,7 ]
Feng, Jing [3 ]
Zhao, Lei [3 ]
Wang, Haoran [3 ]
Chen, Hongye [3 ]
Yan, Wei [3 ]
Guo, Xiao [3 ]
Shi, Shang [3 ]
Li, Zhiyong [3 ]
Wang, Shuang [3 ]
Lu, Yu [3 ]
Zheng, Jianjun [4 ,5 ]
Wei, Yunwei [1 ,2 ,3 ]
机构
[1] Univ Chinese Acad Sci, HwaMei Hosp, Pancreat & Gastrointestinal Surg Div, Ningbo, Peoples R China
[2] Ningbo Clin Res Ctr Digest Syst Tumors, Ningbo, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 1, Oncol & Laparoscopy Surg, Harbin, Peoples R China
[4] Univ Chinese Acad Sci, HwaMei Hosp, Imaging Ctr, Ningbo, Peoples R China
[5] Ningbo Clin Med Res Ctr Imaging Med, Ningbo, Peoples R China
[6] Fujian Med Univ, Affiliated Hosp 1, Gastrointestinal Surg, Fuzhou, Peoples R China
[7] SouthernMed Univ, Zhujiang Hosp, Gen Surg, Guangzhou, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
oral microbiota; xerostomia; differentiated thyroid carcinoma; radioiodine therapy; 16S rRNA; SALIVARY-GLAND FUNCTION; RADIOACTIVE IODINE; CANCER; INFLAMMATION; LIPOPOLYSACCHARIDE; RADIATION; CAVITY;
D O I
10.3389/fendo.2022.895970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and AimsOral xerostomia remains one of the most common complications of differentiated thyroid carcinoma patients (DTC) after radioiodine therapy (RAI). Environmental factors in the etiology of xerostomia are largely unknown. We aimed to characterize the oral microbiota signatures and related biological functions associated with xerostomia and identify environmental factors affecting them. MethodsSaliva was collected from 30 DTC patients with xerostomia (XAs), 32 patients without xerostomia (indicated as non-XAs) following RAI after total thyroidectomy, and 40 healthy people (HCs) for 16S rRNA sequencing analysis. ResultsThe oral microbiota of XAs and non-XAs exhibited significant differences in alpha and beta diversities and bacterial taxa. The abundance of porphyromonas, fusobacterium, and treponema_2 were significantly higher in XAs, while the abundance of the streptococcus was lower in the microbiota of non-XAs. Fusobacterium, and porphyromonas were negatively correlated with unstimulated/stimulated whole salivary secretion (USW)/(SWS), while fusobacterium, porphyromonas, and treponema_2 genera levels were positively associated with cumulative radioiodine dose. PICRUSt2 and BugBase suggested a significant difference in the expression of potentially_pathogenic, anaerobic, gram_negative, the arachidonic acid metabolism, and lipopolysaccharide (LPS) biosynthesis between XAs and non-XAs, possibly interdependent on radioiodine-induced inflammation. NetShift analysis revealed that porphyromonas genus might play as a key driver during the process of xerostomia. Five genera effectively distinguished XAs from non-XAs (AUC = 0.87). ConclusionOur study suggests for the first time that DTC patients with xerostomia after RAI display microbiota profiles and associated functional changes that may promote a pro-inflammatory environment. Dysbiosis of the oral microbiota may contribute to exacerbating the severity of xerostomia. Our results provide a research direction of the interaction mechanism between oral microbiota alteration and the progress of xerostomia.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] RADIOIODINE THERAPY OF BONE METASTASES FROM DIFFERENTIATED THYROID-CARCINOMA
    BESTAGNO, M
    PAGLIAINI, R
    GUERRA, P
    MAIRA, G
    TERZI, A
    GIUBBINI, R
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 71 - 72
  • [42] Retrospective Analysis of Radioiodine Therapy for Differentiated Thyroid Cancer Patients
    Gunes, B.
    Demir, M.
    Kanmaz, B.
    Kabasakal, L.
    Sayman, H.
    Onsel, C.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S446 - S446
  • [43] Radioiodine Therapy in Patients with Stage I Differentiated Thyroid Cancer
    Jonklaas, Jacqueline
    Cooper, David S.
    Ain, Kenneth B.
    Bigos, Thomas
    Brierley, James D.
    Haugen, Bryan R.
    Ladenson, Paul W.
    Magner, James
    Ross, Douglas S.
    Skarulis, Monica C.
    Steward, David L.
    Maxon, Harry R.
    Sherman, Steven I.
    THYROID, 2010, 20 (12) : 1423 - 1424
  • [44] Lung metastases in patients with differentiated thyroid carcinoma - evaluation of response to radioiodine therapy in children and in adults
    Sousa, R.
    Vaz, S.
    Silva, A.
    Ferreira, T. C.
    Ratao, P.
    Carvalho, I. D.
    Daniel, A.
    Salgado, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S544 - S544
  • [45] Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma
    Luster, M
    Lassmann, M
    Haenscheid, H
    Michalowski, U
    Incerti, C
    Reiners, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10): : 3640 - 3645
  • [46] SEQUENTIAL-CHANGES IN SERUM THYROID PEROXIDASE FOLLOWING RADIOIODINE THERAPY OF PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    OZATA, M
    BAYHAN, H
    BINGOL, N
    DUNDAR, S
    BEYHAN, Z
    CORAKCI, A
    GUNDOGAN, MA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12): : 3634 - 3638
  • [47] Definition of the Response to Initial Therapy with Radioiodine in Patients with Differentiated Thyroid Carcinoma: Basal or Stimulated Thyroglobulin?
    Rosario, Pedro Weslley
    Mourao, Gabriela Franco
    Calsolari, Maria Regina
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (10) : 634 - 638
  • [48] A Prospective Study of the Effect of Radioiodine Therapy on Ovarian Reserve Function in Patients with Differentiated Thyroid Carcinoma
    Miao, W.
    Lin, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S143 - S143
  • [49] The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma
    Tsang, TW
    Brierley, JD
    Simpson, WJ
    Panzarella, T
    Gospodarowicz, MK
    Sutcliffe, SB
    CANCER, 1998, 82 (02) : 375 - 388
  • [50] Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Patients with Metastatic Differentiated Thyroid Carcinoma
    Zagar, Ivana
    Schwarzbartl-Pevec, Andreja A.
    Vidergar-Kralj, Barbara
    Horvat, Rika
    Besic, Nikola
    JOURNAL OF THYROID RESEARCH, 2012, 2012